The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Transaction #20399 · Form 4 · 0001104659-25-121626

DIVERSIFIED HEALTHCARE TRUST · Purchase · Common Shares of Beneficial Interest

DIVERSIFIED HEALTHCARE TRUST · Transacted December 15, 2025 · Filed December 16, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for DIVERSIFIED HEALTHCARE TRUST records a purchase involving Common Shares of Beneficial Interest on December 15, 2025. The reported quantity was 20,000. The filing date is December 16, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001075415
Security type
Non-derivative
Acquisition type
Purchase · Code P
Quantity acquired
20,000
Reported price
4.886 · See footnotes
Reference value
97,720
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
266,284.908
Ownership description
Not reported
SEC acceptance time
Dec 16, 2025, 4:44 PM EST
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

DHC · NasdaqDHCNI · NasdaqDHCNL · Nasdaq

This transaction is not mapped to a specific company listing.

Filing footnotes & remarks

F1
The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $4.88 to $4.89 per share. Mr. Bilotto undertakes to provide to Diversified Healthcare Trust (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2
Includes 385.018 shares acquired under a dividend reinvestment plan since the last Section 16 filing by Mr. Bilotto.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.